The mass spec immunoassay (MSIA) workflow was developed to provide a simple, automated process for purification of targeted analytes for downstream detection using multiple analytical techniques, such as mass spectrometry.
Niederkofler describes benefits of the automated mass spec immunoassay workflow.
Eric Niederkofler, R&D Manager, Thermo Fisher Scientific, presents an integrated approach using Tecan automated liquid handlers (Freedom EVO® platform) and proprietary Thermo MSIA™ microcolumns. In addition to how the technology works, Mr. Niederkofler presents the benefits and real world customer case studies on insulin and botulinum neurotoxin.
Discover the benefits of automation in the mass spec immunoassay (MSIA) workflow. Watch the video now.
About the author
Nicholas Smith is Head of Global Marketing and Portfolio Management for Tecan’s Partnering Business. A key function of his team is to work closely with customers to develop new product concepts and proposals based on a thorough analysis of their specific requirements. Nicholas’ joined Tecan in 2012 from Roche Diagnostics where he worked for over 20 years in a variety of roles within marketing and business development.